Immunome Inc. — Director's Dealing 2020

Dec 10, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2020-11-30

Reporting Person: Marcou Diane M (Interim CFO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.40	2030-08-03	Common Stock (8333)		Direct

Footnotes

F1: The option became fully exercisable in four equal monthly installments with the last vesting date occurring on December 4, 2020.